医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

幹細胞

SIRION Biotech to Participate in Major International Industry Conferences

バイオテクノロジーヘルスケア幹細胞製薬遺伝学　 TimeLine: SIRION Biotech to Participate in Major

2019年10月01日

SanBio Granted Regenerative Medicine Advanced Therapy Designation from the U.S. FDA for SB623 for the Treatment of Chronic Neurological Motor Deficits Secondary to Traumatic Brain Injury

SanBio Granted Regenerative Medicine Advanced Therapy Designation from the U.S. FDA for SB623 for the Treatment of Chronic Neurological Motor Deficits Secondary to Traumatic Brain Injury

バイオテクノロジーヘルスケア幹細胞臨床試験製薬遺伝学　 TimeLine: FDA for SB623 for the Treatment SanBio Granted Regenerative Medicine Advanced

2019年09月19日

AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

バイオテクノロジーヘルスケアヘルス一般幹細胞病院臨床試験製薬　 TimeLine: AVITA Medical Receives U.S FDA Investigational Device Exemption Approval

2019年09月17日

IMS Reports the Multidisciplinary Approaches to Minimally Invasive Cancer Treatment Using JCI MN Colloidal Iodine

その他ヘルスヘルスケアヘルス一般幹細胞腫瘍学臨床試験製薬　 TimeLine: IMS Reports the Multidisciplinary Approaches

2019年09月06日

AVITA Medical Added to the S&P/ASX 300 Index

AVITA Medical Added to the S&P/ASX 300 Index

バイオテクノロジーヘルスケアヘルス一般幹細胞病院製薬　 TimeLine: ASX 300 Index AVITA Medical Added to the S&amp

2019年09月06日

Astex Pharmaceuticals Announces That Its Novel, Oral Hypomethylating Agent ASTX727 Has Been Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes (Including Chronic Myelomonocytic Leukemia) by the US FDA

Astex Pharmaceuticals Announces That Its Novel, Oral Hypomethylating Agent ASTX727 Has Been Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes (Including Chronic Myelomonocytic Leukemia) by the US FDA

バイオテクノロジーヘルスケア幹細胞腫瘍学臨床試験製薬　 TimeLine: Astex Pharmaceuticals Announces That Its Novel by the US FDA Including Chronic Myelomonocytic Leukemia Oral Hypomethylating Agent ASTX727 Has Been

2019年09月04日

Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP

バイオテクノロジーヘルスケア幹細胞腫瘍学製薬　 TimeLine: Propanc Biopharma Receives Granted US Patent

2019年08月21日

2019年江戸川NICHE賞は免疫療法によりがんとの闘いで先駆的な偉業を成し遂げたスティーブン・ローゼンバーグ博士に授与

2019年江戸川NICHE賞は免疫療法によりがんとの闘いで先駆的な偉業を成し遂げたスティーブン・ローゼンバーグ博士に授与

ヘルスケア外科幹細胞腫瘍学製薬　 TimeLine: 2019年江戸川NICHE賞スティーブン・ローゼンバーグ博士偉業免疫療法授与

2019年08月16日

Steven Rosenberg博士因其癌症免疫治疗的先驱性工作而荣获2019年江户川NICHE奖

Steven Rosenberg博士因其癌症免疫治疗的先驱性工作而荣获2019年江户川NICHE奖

ヘルスケア外科幹細胞腫瘍学製薬　 TimeLine: Steven Rosenberg博士因其癌症

2019年08月16日

2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy

2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy

ヘルスケア外科幹細胞腫瘍学製薬　 TimeLine: 2019 Edogawa NICHE Prize Awarded to Dr Steven Rosenberg for His Pioneering Feat

2019年08月15日